Gilliland Jeter Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Gilliland Jeter Wealth Management's PFE Position: Q1 2026 in Review
Gilliland Jeter Wealth Management increased its Pfizer (PFE) stake by 0.14% in Q1 2026, buying an estimated $825 and bringing the position to 22,529 shares worth $633K. The position accounts for 0.19% of the portfolio, ranked #97.
Gilliland Jeter Wealth Management first reported a position in PFE in Q4 2023 and has held it in 10 quarters since. The position peaked at $962K in Q4 2023. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Gilliland Jeter Wealth Management held 22,529 shares of Pfizer worth $633K as of Q1 2026.
- Gilliland Jeter Wealth Management bought 31 Pfizer shares in Q1 2026, an estimated $825.
- Pfizer made up 0.19% of Gilliland Jeter Wealth Management's portfolio in Q1 2026, its #97 holding.
- Gilliland Jeter Wealth Management first reported a position in Pfizer in Q4 2023 and has held it in 10 quarters since.
- Gilliland Jeter Wealth Management's Pfizer position peaked at $962K in Q4 2023.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Gilliland Jeter Wealth Management's 13F filing for Q1 2026, filed 24 Apr 2026.